Bangladesh Sentences Nobel Peace Prize Winner To 6 Months In Prison
(Bloomberg) -- A Dhaka court sentenced Muhammad Yunus — who won the Nobel Peace Prize for pioneering microloans to some of Bangladesh's poorest — to 6 months in jail for labor law violations.
A labor inspector had found that employees of Grameen Telecom, of which Yunus, 83, is chairman, were denied benefits including leave and welfare deposits. He has denied the allegations.
“We're being punished for something we haven't done,” Yunus said after the verdict. “That's our fate and that's the fate of our nation.”
Judge Sheikh Marina Sultana granted Yunus and three other officials of Grameen Telecom bail for one month, allowing them to appeal the sentencing in the High Court. Yunus's lawyer Abdullah Al Mamun said he will appeal the verdict.
Grameen Telecom, a non-profit organization, owns 34.2% of Bangladesh's largest telecom carrier Grameenphone, a unit of Norway's Telenor ASA.
This is one of about 150 cases filed against Yunus after Prime Minister Sheikh Hasina Wajed's Awami League came to power in 2008, according to Amnesty International. The case is “emblematic of the beleaguered state of human rights in Bangladesh, where the authorities have eroded freedoms and bulldozed critics into submission,” Agnès Callamard, secretary general of Amnesty, said in September.
Hasina has publicly attacked Yunus on many occasions. In 2011, she accused him of “sucking blood from the poor.” In 2022, she alleged that he tried to block World Bank funding of the Padma bridge project. Yunus has denied any role in freezing funds for the bridge project.
(Adds quote from Yunus in third paragraph)
More stories like this are available on bloomberg.com
©2024 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.